'Chronic phase' presentation slideshows

1k views • 88 slides

Contact Dermatitis

Contact Dermatitis. Basic Dermatology Curriculum. Last updated July 21, 2011. Module Instructions.

793 views • 68 slides

Myeloproliferative disorders

Myeloproliferative disorders. Clonal haematopoeitic disorders Proliferation of one of myeloid lineages Granulocytic Erythroid Megakaryocytic Relatively normal maturation. Myeloproliferative disorders. WHO Classification of CMPD Ch Myeloid leukemia Ch Neutrophillic leukemia

882 views • 60 slides

Overview of Hematopoietic Diseases and Their Treatments Gregory Monohan, M.D.

Overview of Hematopoietic Diseases and Their Treatments Gregory Monohan, M.D. Kentucky Cancer Registry 2012. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. >20 Types of Leukemia >30 Types of Lymphomas CANCEROUS BLOOD CELL. Hematopoiesis. Hematopoiesis (Microenvironment).

905 views • 54 slides

A Brief overview of Vector-Borne IIlness N5290 The Science of Nursing in the Community

A Brief overview of Vector-Borne IIlness N5290 The Science of Nursing in the Community Jill Gallin, CPNP Assistant Professor of Clinical Nursing Columbia University. Global Distribution of Schistosomiasis in Africa and the Americas: S. mansoni, S. intercalatum.

576 views • 45 slides

Alcoholism Update

Alcoholism Update. Nursing Education Day 2005. Epidemiology. Lifetime prevalence between 10-20% 18.6% of men and 8.4% of women will experience an alcohol dependence diagnosis in their lifetime 1/3 of children of alcoholics become alcoholics. Statistics.

629 views • 43 slides

523 views • 40 slides

Diabetic neuropathy

4.69k views • 37 slides

American Trypanosomiasis Chagas Disease

American Trypanosomiasis Chagas Disease. New World Trypanosomiasis South American Trypanosomiasis Mal de Chagas Chagas-Mazza Disease. Overview. Organism History Epidemiology Transmission Disease in Humans Disease in Animals Prevention and Control Actions to Take. Organism.

619 views • 37 slides

CHRONIC MYELOID LEUKEMIA, THE TUNISIAN EXPERIENCE IN IMATINIB ERA

481 views • 36 slides

CHAGAS DISEASE Serological Diagnosis and the humoral immune response after specific treatment

468 views • 29 slides

Chronic myeloproliferative disease

Chronic myeloproliferative disease. ???? ???? ?????? ????? ??????? ?????? ????. ????????? ??????????????? ?? ??? ??????? ?????? ????? ? ??? ??????? ???????? ?????. ??????????? ????? ???? ???. ??????? ?? ?????? ?? ????? ??? ????? ???? ?? ?? ??? ???? ?????? ????. ?????? Old age ?????.

662 views • 29 slides

393 views • 29 slides

An Architecture for Rehabilitation Task Practice in Socially Assistive Human-Robot Interaction

An Architecture for Rehabilitation Task Practice in Socially Assistive Human-Robot Interaction . Ross Mead Eric Wade Pierre Johnson Aaron St. Clair Shuya Chen Maja J Matari?. Hello, my name is Bandit. I am here to assist you!. Motivation: Post-Stroke Rehabilitation.

369 views • 21 slides

WOUND CARE

WOUND CARE. Presentation for ACC Lab March 22, 2006 By Herlinda M. Burks, RN, BA, CWCN, CCCN. Risk Assessments. Report: focus on Hx of diseases, surgeries, how recent, present wounds, incisions. Read the H&P. 10 minute assessment What do you see?

802 views • 19 slides

WOUND CARE

WOUND CARE. By Helen Harkreader, RN, PhD. Wound Healing Processes . Types of Wound Closures Primary Intention Sutures, staples, skin bonds, etc. Secondary Intention Partial thickness Regenerate specific cells Epithelialize Full thickness Regranulate Epithelialize Remodel

706 views • 17 slides

Spinal cord injury

Spinal cord injury. R2 ??? 2003/1/16. Pathophysiology of spinal cord injury. Primary injury: hemarrhage, and perhaps vasospasm, immediate reduction of blood flow Secondary injury: infarction of spinal cord with permanent loss of function

703 views • 15 slides

Hughes TP et al. Proc ASH 2010 ; Abstract 207.

ENESTnd 24-Month Update: Continued Superiority of Nilotinib versus Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP). Hughes TP et al. Proc ASH 2010 ; Abstract 207. ENESTnd Study Schema. Imatinib 400 mg PO QD (n = 283). R. Nilotinib

335 views • 11 slides

Scheid, R; Cramon , D Y v

162 views • 5 slides

SMC were significantly associated with: Increased age; Increased time-since-injury;

Determinants of Subjective Memory Complaints in Community-dwelling Adults with Traumatic Brain Injury Esther Bay, PhD; Bruno Giordani, PhD; Claire Kalpakjian, PhD The University of Michigan, Ann Arbor, MI. Introduction. Methods. Results.

84 views • 1 slides